{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T15:05:46Z","timestamp":1766847946235,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.soc.2022.03.010","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T17:09:32Z","timestamp":1654016972000},"page":"511-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Management of Skin Sarcomas"],"prefix":"10.1016","volume":"31","author":[{"given":"Valentina","family":"Messina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Cope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8783-8484","authenticated-orcid":false,"given":"Emily Z.","family":"Keung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8220-424X","authenticated-orcid":false,"given":"Marco","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.soc.2022.03.010_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/PAT.0000000000000046","article-title":"Cutaneous mesenchymal tumours: an update","volume":"46","author":"Mentzel","year":"2014","journal-title":"Pathology"},{"issue":"30","key":"10.1016\/j.soc.2022.03.010_bib2","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1200\/JCO.2005.02.5122","article-title":"Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate","volume":"23","author":"Fiore","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.soc.2022.03.010_bib3","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00000478-200008000-00010","article-title":"Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up","volume":"24","author":"Goldblum","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.soc.2022.03.010_bib4","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/cncr.20678","article-title":"Dermatofibrosarcoma","volume":"101","author":"Mendenhall","year":"2004","journal-title":"Protuberans Cancer"},{"journal-title":"Soft Tissue and Bone Tumours","article-title":"WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 3; 100-103). https:\/\/publications.iarc.fr\/588.","year":"2020","key":"10.1016\/j.soc.2022.03.010_bib5"},{"issue":"11","key":"10.1016\/j.soc.2022.03.010_bib7","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1245\/s10434-019-07494-6","article-title":"Watch and wait approach for re-excision after unplanned yet macroscopically complete excision of extremity and superficial truncal soft tissue sarcoma is safe and does not affect metastatic risk or amputation rate","volume":"26","author":"Decanter","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.soc.2022.03.010_bib8","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"issue":"17","key":"10.1016\/j.soc.2022.03.010_bib9","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.ejca.2015.06.108","article-title":"Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline","volume":"51","author":"Saiag","year":"2015","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.soc.2022.03.010_bib10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1245\/s10434-019-08012-4","article-title":"Margins in DFSP Reconsidered: Primum Non Nocere","volume":"27","author":"van Houdt","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2022.03.010_bib11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0360-3016(97)00895-X","article-title":"The role of radiation therapy in the management of dermatofibrosarcoma protuberans","volume":"40","author":"Ballo","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.soc.2022.03.010_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1158\/1078-0432.CCR-13-1411","article-title":"Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up","volume":"20","author":"Ugurel","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.soc.2022.03.010_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/cncr.31924","article-title":"Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated?","volume":"125","author":"Huis In \u2019t Veld","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.soc.2022.03.010_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anndiagpath.2010.07.012","article-title":"Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007","volume":"15","author":"Albores-Saavedra","year":"2011","journal-title":"Ann Diagn Pathol"},{"issue":"8","key":"10.1016\/j.soc.2022.03.010_bib15","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/cncr.11667","article-title":"Cutaneous angiosarcoma of the scalp: a multidisciplinary approach","volume":"98","author":"Pawlik","year":"2003","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.soc.2022.03.010_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jclinpath-2015-203545","article-title":"Sarcoma of the breast: an update on a rare entity","volume":"69","author":"Lim","year":"2016","journal-title":"J\u00a0Clin Pathol"},{"issue":"5","key":"10.1016\/j.soc.2022.03.010_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hed.21513","article-title":"Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp","volume":"33","author":"Guadagnolo","year":"2011","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.soc.2022.03.010_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.bjc.6601920","article-title":"Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature","volume":"91","author":"Adem","year":"2004","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.soc.2022.03.010_bib19","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1245\/s10434-006-9335-y","article-title":"Treatment and outcome of 82 patients with angiosarcoma","volume":"14","author":"Abraham","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2022.03.010_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0360-3016(99)00444-7","article-title":"An analysis of 78 breast sarcoma patients without distant metastases at presentation","volume":"46","author":"McGowan","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.soc.2022.03.010_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.amjsurg.2008.06.010","article-title":"Treatment and outcomes of patients with primary breast sarcoma","volume":"196","author":"Fields","year":"2008","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.soc.2022.03.010_bib22","first-page":"505","article-title":"Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience","volume":"116","author":"Gutman","year":"1994","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.soc.2022.03.010_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/1097-0142(194805)1:1<64::AID-CNCR2820010105>3.0.CO;2-W","article-title":"Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica","volume":"1","author":"Stewart","year":"1948","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.soc.2022.03.010_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0360-3016(91)90783-Z","article-title":"Long-term risk of sarcoma following radiation treatment for breast cancer","volume":"21","author":"Taghian","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.soc.2022.03.010_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02303543","article-title":"Post-treatment sarcoma in breast cancer patients","volume":"1","author":"Brady","year":"1994","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2022.03.010_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000445427","article-title":"Stewart-treves syndrome: a case report and review of the literature","volume":"9","author":"Berebichez-Fridman","year":"2016","journal-title":"Case Rep Oncol"},{"issue":"2","key":"10.1016\/j.soc.2022.03.010_bib27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/1097-0142(197208)30:2<562::AID-CNCR2820300237>3.0.CO;2-V","article-title":"Lymphangiosarcoma arising in chronic lymphedematous extremities","volume":"30","author":"Woodward","year":"1972","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.soc.2022.03.010_bib28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1096-9098(200003)73:3<182::AID-JSO14>3.0.CO;2-N","article-title":"Role of surgery in the management of postmastectomy extremity angiosarcoma (Stewart-Treves syndrome)","volume":"73","author":"Grobmyer","year":"2000","journal-title":"J\u00a0Surg Oncol"},{"issue":"765","key":"10.1016\/j.soc.2022.03.010_bib29","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1259\/0007-1285-64-765-857","article-title":"Post-mastectomy lymphangiosarcoma (Stewart-Treves syndrome): report of two long-term survivals","volume":"64","author":"Kaufmann","year":"1991","journal-title":"Br J Radiol"},{"key":"10.1016\/j.soc.2022.03.010_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2017.07.023","article-title":"Isolated limb perfusion for locally advanced angiosarcoma in extremities: A multi-centre study","volume":"85","author":"Huis In \u2019t Veld","year":"2017","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.soc.2022.03.010_bib31","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/BF02574520","article-title":"Isolated limb perfusion with tumor necrosis factor and melphalan for nonresectable sSewart-Treves lymphangiosarcoma","volume":"9","author":"Lans","year":"2002","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2022.03.010_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.radonc.2007.10.015","article-title":"Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network","volume":"85","author":"Bousquet","year":"2007","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.soc.2022.03.010_bib33","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/PAS.0b013e31825359e1","article-title":"Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma","volume":"36","author":"Miller","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.soc.2022.03.010_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/DAD.0b013e3181c80b97","article-title":"Atypical fibroxanthoma: a histological and immunohistochemical review of 171 cases","volume":"32","author":"Beer","year":"2010","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.soc.2022.03.010_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cup.13787","article-title":"Atypical fibroxanthoma and pleomorphic dermal sarcoma: a reappraisal","volume":"48","author":"Cesinaro","year":"2021","journal-title":"J\u00a0Cutan Pathol"},{"issue":"8","key":"10.1016\/j.soc.2022.03.010_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11864-017-0489-6","article-title":"Conception and management of a poorly understood spectrum of dermatologic neoplasms: atypical fibroxanthoma, pleomorphic dermal sarcoma, and undifferentiated pleomorphic sarcoma","volume":"18","author":"Soleymani","year":"2017","journal-title":"Curr Treat Options Oncol"},{"issue":"5","key":"10.1016\/j.soc.2022.03.010_bib37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1524-4725.2009.01126.x","article-title":"More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?","volume":"35","author":"Ang","year":"2009","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.soc.2022.03.010_bib38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/modpathol.2013.168","article-title":"TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas","volume":"27","author":"Griewank","year":"2014","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.soc.2022.03.010_bib39","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/DSS.0000000000001943","article-title":"Atypical Fibroxanthoma: the washington university experience","volume":"45","author":"Phelan","year":"2019","journal-title":"Dermatol Surg"},{"issue":"21","key":"10.1016\/j.soc.2022.03.010_bib40","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1158\/1078-0432.CCR-20-1899","article-title":"Integrative analysis of pleomorphic dermal sarcomas reveals fibroblastic differentiation and susceptibility to immunotherapy","volume":"26","author":"Klein","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.soc.2022.03.010_bib41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncr.22395","article-title":"Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group","volume":"109","author":"Svarvar","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.soc.2022.03.010_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2559.2009.03471.x","article-title":"Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases","volume":"56","author":"Massi","year":"2010","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.soc.2022.03.010_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/ajd.13307","article-title":"Cutaneous leiomyosarcoma: dermal and subcutaneous","volume":"61","author":"Wong","year":"2020","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.soc.2022.03.010_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jso.26262","article-title":"Treatment outcome of superficial leiomyosarcoma","volume":"123","author":"Wellings","year":"2021","journal-title":"J\u00a0Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2022.03.010_bib45","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e31820e6093","article-title":"Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous \u201cleiomyosarcoma","volume":"35","author":"Kraft","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.soc.2022.03.010_bib46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12032-018-1196-2","article-title":"Primary leiomyosarcoma of the skin: a comprehensive review on diagnosis and treatment","volume":"35","author":"Zacher","year":"2018","journal-title":"Med Oncol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320722000230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320722000230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:07:32Z","timestamp":1760962052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320722000230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1055320722000230"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2022.03.010","relation":{},"ISSN":["1055-3207"],"issn-type":[{"type":"print","value":"1055-3207"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Skin Sarcomas","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2022.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}